Portal branch occlusion safely facilitates in vivo retroviral vector transduction of rat liver

Human Gene Therapy

Volumn 7, Issue 17, 1996, Pages 2113-2121

  Bowling, William M ^a   Kennedy, Susan C ^a   Cai, Shi Rong ^a   Duncan, James R ^a   Gao, Cuihua ^a   Flye, M Wayne ^a   Ponder, Katherine Parker ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TOXIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DIVISION; CONTROLLED STUDY; EXPRESSION VECTOR; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENETIC DISORDER; GENETIC TRANSDUCTION; LIVER CANCER; LIVER CELL; LIVER REGENERATION; MORBIDITY; NONHUMAN; PARTIAL HEPATECTOMY; PORTAL VEIN OBSTRUCTION; PROMOTER REGION; RAT; RETROVIRUS;

ANIMALIA; UNIDENTIFIED RETROVIRUS;

EID: 0029849258     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.17-2113     Document Type: Article

References (40)

1. BRANCHEREAU, S., CALISE, D., and FERRY, N. (1994). Factors influencing retroviral-mediated gene transfer into hepatocytes in vivo. Hum. Gene Ther. 5, 803-808.
2. BURCHARTH, F. (1979). Percutaneous transhepatic portography. I. Technique and application. Am. J. Roentgoenol. 132, 177-182.
3. CARBALHAES, O.G. (1959). Portography: A preliminary report of a new technique via the umbilical vein. Clin Proc. Child Hosp 15, 120-122.
4. CARDOSO, J.E., BRANCHEREAU, S., ROY, J.P., HOUSSIN, D., DANOS, O., and HEARD, J.M. (1993). In situ retrovirus mediated gene transfer into dog liver. Hum. Gene Ther. 4, 411-418.
5. CHOWDHURY, J.R., GROSSMAN, M., GUPTA, S., CHOWDHURY, N.R., BAKER, J.R., and WILSON, J.M. (1991). Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDL-R deficient rabbits. Science 254, 1802-1804.
6. COHN, S.M., and LIEBERMAN, M.W. (1984). The use of antibodies to 5′-bromo-2′-deoxyuridine for the isolation of DNA sequences containing excision-repair sites. J. Biol. Chem. 259, 12456-13462.
7. DEBAERE, T., ROCHE, A., VAVASSEUR, D., THERASSE, E., INDUSHEKAR, S., ELIAS, D., and BOGNEL, C. (1993). Portal vein embolization: Utility for inducing left hepatic lobe hypertrophy before surgery. Cardiovasc. Radiol. 188, 73-77.
8. FERRY, N., DUPLESSIS, O., HOUSSIN, D., DANOS, O., and HEARD, J.M. (1991). Retroviral-mediated gene transfer into hepatocytes in vivo. Proc. Natl. Acad. Sci. USA 88, 8377-8381.
9. 3. Cancer Res. 22, 842-849.
10. GROSSMAN, M., RAPER, S.E., and WILSON, J.M. (1992). Transplantation of genetically modified autologous hepatocytes into nonhuman primates: feasibility and short-term toxicity. Hum. Gene Ther. 3, 501-510.
11. GROSSMAN, M., RADAR, D.J., MULLER, D.W.N., KOLANSKY, D.M., KOZARSKY, K., CLARD, B.J., STEIN, E.A., LUPIEN, P.J., BREWER, H.B., RAPER, S.E., and WILSON, J.M. (1995). A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolemia. Nature Med. 1, 1148-1154.
12. HARLOW, E., and LANE, D. (1988). Cell staining. In Antibodies: A Laboratory Manual. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY) pp. 359-420.
13. HONJO, I., SUZUKI, T., OZAWA, K., TAKASAN, H., KITAMURA, O., and ISHIKAWA, T. (1975). Ligation of a branch of the portal vein for carcinoma of the liver. Am. J. Surg. 130, 296-302.
14. IKEDA, K., KINOSHITA, H., HIROHASHI, K., KUBO, S., and KANADA, K. (1995). The ultrastructure, kinetics, and intralobular distribution of apoptotic hepatocytes after portal branch ligation with special reference to their relationship to necrotic hepatocytes. Arch. Histol. Cytol. 58, 171-184.
15. KALEKO, M., GARCIA, J., and MILLER, A.D. (1991). Persistent expression after retroviral gene transfer into liver cells in vivo. Hum. Gene Ther. 2, 27-32.
16. 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes. Proc. Natl. Acad. Sci. USA 89, 89-93.
17. KAY, M.A., ROTHENBERG, S., LANDEN, C.N., BELLINGER, D.A., LELAND, F., TOMAN, C., FINEGOLD, M., THOMPSON, A.R., READ, M.S., BRINKHOUS, K.M., and WOO, S.L.C. (1993). In vivo gene therapy of hemophilia B: Sustained partial correction in Factor IX deficient dogs. Science 266, 117-119.
18. KERR, J.F.R. (1971). Shrinkage necrosis: a distinct mode of cellular death. J. Pathol. 105, 13-20.
19. KINOSHITA, H., SAKAI, K., HIROHASHI, K., IGAWA, S., YAMASAKI, O., and KUBO, S. (1986). Preoperative portal vein embolization for hepatocellular carcinoma. World J. Surg. 10, 803-808.
20. KOLODKA, T.M., FINEGOLD, M., and WOO, S.L.C. (1993). Hepatic gene therapy: Efficient retroviral mediated gene transfer into rat hepatocytes in vivo. Somatic Cell Mol. Genet. 19, 491-497.
21. LE, M.T., OKUYAMA, T., CAI, S.R., KENNEDY, S., BOWLING, W.M., FLYE, M.W., and PONDER, K.P. Therapeutic levels of functional human Factor X in rats after retroviral-mediated hepatic gene therapy. Blood (in press).
22. LEDLEY, F.R. (1993). Hepatic gene therapy: Present and future. Hepatology 18, 1263-1273.
23. LIEBER, A., VRANCKEN PEETERS, M.J., MUESE, L., FAUSTO, N., PERKINS, J., and KAY, M.A. (1995a). Adenovirus-mediated urokinase gene transfer induces liver regeneration and allows for efficient retrovirus transduction of hepatocytes in vivo. Proc. Natl. Acad. Sci USA 92, 6210-6214.
24. LIEBER, A., VRANCKEN PEETERS, M.-J.T.F.D, GOWN, A., PERKINS, J., and KAY, M.A. (1995b). A modified urokinase activator induces liver regeneration without bleeding. Hum. Gene Ther. 6, 1029-1037.
25. MAKUUCHI, M., KOSUGE, T., and LYGIDAKIS, N.J. (1991). New possibilities for major liver surgery in patients with Klatskin tumors or primary hepatocellular carcinoma- an old problem revisited. Hepato-Gastroenterology 38, 329-336.
26. MILLER, A.D., and ROSMAN, G.J. (1989). Improved retroviral vectors for gene transfer and expression. Biotechniques 7, 980-990.
27. MILLER, D.G., ADAM, M.A., and MILLER, A.D. (1990). Gene transfer by retroviral vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol. 10, 4239-4242.
28. NALDINI, L., BLOMER, U., GALLEY, P., ORY, D., MULLIGAN, R., GAGE, F.H., VERMA, I.M., and TRONO, D. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267.
29. 1-antitrypsin in vivo. Hum. Gene Ther. 7, 637-645.
30. OZAWA, K., KITAMURA, O., YAMAOKA, Y., KAMANO, T., MIZUKAMI, T., TAKEDA, H., TAKASAN, H., and HONJO I. (1973). Metabolic responses of the liver of human beings and other mammals to deprivation of portal blood supply. Surg. Gynecol. Obstet. 137, 623-628.
31. PONDER, K.P. (1996). Gene delivery for systemic expression. In Gene Therapy for Cardiovascular Disorders. K. March, ed. (W.B. Saunders, Philadelphia) in press.
32. PONDER, K.P., GUPTA, S., LELAND, F., DARLINGTON, G., FINEGOLD, M., DeMAYO, J., LEDLEY, F., CHOWDHURY, J., and WOO, S.L.C. (1991). Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation. Proc. Natl. Acad. Sci. USA 88, 1217-1221.
33. RETTINGER, S.D., KENNEDY, S.C., WU, X., SAYLORS, R.L., HAFENRICHTER, D.G., FLYE, M.W., and PONDER, K.P. (1994). Liver-directed gene therapy: Quantitative evaluation of promoter elements by using in vivo retroviral transduction. Proc. Natl. Acad. Sci. USA 91, 1460-1464.
34. ROCSH, J., HANAFEE, W.N., and SHOW, H. (1969). Transjugular portal venography and radiologic portacaval shunt: an experimental study. Radiology 92, 1112-1114.
35. ROZGA, J., JEPPSSON, B., and BENGMARK, S. (1986). Portal branch ligation in the rat. Reevaluation of a model. Am. J. Pathol. 125, 300-308.
36. STEINER, P.E., and MARTINEZ, J.B. (1961). Effects on the rat liver of bile duct, portal vein, and hepatic artery ligation. Am. J. Pathol. 39, 257-289.
37. TAYLOR, I., BENNETT, R., and SHERRIFF, S. (1979). The blood supply of colorectal liver metastases. Br. J. Cancer 39, 749-756.
38. THOMPSON, A.R. (1995). Progress towards gene therapy for the hemophilias. Thromb. Hemost. 74, 45-51.
39. WILSON, J.M., CHOWDHURY, N.R., GROSSMAN, M., WAJSMAN, R., EPSTEIN, A., MULLIGAN, R.C., and CHOWDHURY, J.R. (1990). Temporary amelioration of hyperlipidemia in low density lipoprotein receptor-deficient rabbits transplanted with genetically modified hepatocytes. Proc. Natl. Acad. Sci. USA 87, 8437-8441.
40. YAMAKADO, K., TAKEDA, K., NISHIDE, Y., JIN, J., MATSUMURA, K., NAKATSUKA, A., HIRANO, T., KATO, N., and NAKAGAWA, T. (1995). Portal vein embolization with steel coils and absolute ethanol: A comparative study with canine liver. Hepatology 22, 1812-1818.